China Pharma Holdings (CPHI) Change in Taxes (2010 - 2020)
China Pharma Holdings' (CPHI) quarterly Change in Taxes came in at -$155827.0 in Q3 2020, down 332.74% YoY from $66953.0 in Q4 2019, and down 168.57% on a QoQ basis from $227245.0 in Q2 2020.
China Pharma Holdings (CPHI) Change in Taxes (2010 - 2020) Analysis & Trends
China Pharma Holdings (CPHI) has 11 years of Change in Taxes data on file, last reported at -$155827.0 in Q3 2020.
- Quarterly Change in Taxes fell 332.74% year-over-year to -$155827.0 in Q3 2020, while the trailing twelve-month figure through Sep 2020 was $113571.0 (up 1315.18% YoY) and the FY2019 annual result came in at $12971.0, up 108.82% from the prior year.
- Change in Taxes eased to -$155827.0 in Q3 2020, from $227245.0 in the prior quarter.
- In the past five years, Change in Taxes ranged from a high of $227245.0 in Q2 2020 to a low of -$163335.0 in Q1 2018.
- A 5-year average of $4244.9 and a median of -$10350.0 in 2019 frame the typical range for Change in Taxes.
- Annual changes were most pronounced in 2017 — Change in Taxes sank 413.54% — and 2020, when it jumped 2655.49%.
- Tracing CPHI's Change in Taxes over 5 years: stood at $146187.0 in 2016, then slumped by 88.35% to $17034.0 in 2017, then tumbled by 291.78% to -$32667.0 in 2018, then soared by 68.32% to -$10350.0 in 2019, then slumped by 1405.57% to -$155827.0 in 2020.
- The last three Change in Taxes figures came in at -$155827.0 (Q3 2020), $227245.0 (Q2 2020), and $52503.0 (Q1 2020), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.98 Bn | 43.02 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.28 Bn | 39.62 Bn | 2.15 Bn | - |
| 3 | Zoetis | 31.79 Bn | 30.11 Bn | 1.05 Bn | -66.00 Mn |
| 4 | Takeda Pharmaceutical | 28.69 Bn | 22.89 Bn | 5.10 Bn | -106.03 Mn |
| 5 | United Therapeutics | 22.25 Bn | 19.58 Bn | 683.80 Mn | - |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | 40.90 Mn |
| 7 | Neurocrine Biosciences | 15.58 Bn | 15.19 Bn | 935.80 Mn | -59.60 Mn |
| 8 | Elanco Animal Health | 11.87 Bn | 11.34 Bn | 798.00 Mn | - |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - | - |
| 10 | China Pharma Holdings | 42.13 Mn | 41.82 Mn | 83,566.00 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2020 | -155,827.00 |
| Sep 30, 2020 | -155,827.00 |
| Jun 30, 2020 | 227,245.00 |
| Jun 30, 2020 | 227,245.00 |
| Mar 31, 2020 | 52,503.00 |
| Mar 31, 2020 | 52,503.00 |
| Dec 31, 2019 | -10,350.00 |
| Dec 31, 2019 | -10,350.00 |
| Sep 30, 2019 | 66,953.00 |
| Sep 30, 2019 | 66,953.00 |
| Jun 30, 2019 | 8,247.00 |
| Jun 30, 2019 | 8,247.00 |
| Mar 31, 2019 | -51,879.00 |
| Mar 31, 2019 | -51,879.00 |
| Dec 31, 2018 | -32,667.00 |
| Dec 31, 2018 | -32,667.00 |
| Sep 30, 2018 | -20,016.00 |
| Sep 30, 2018 | -20,016.00 |
| Jun 30, 2018 | 68,919.00 |
| Jun 30, 2018 | 68,919.00 |